A systematic review of the efficacy of ketamine for craniofacial pain

BACKGROUND: Craniofacial pain (CFP) poses a burden on patients and health care systems. It is hypothesized that ketamine, an N-methyl-d-aspartate (NMDA) receptor antagonist, can reverse central sensitization associated with causation and propagation of CFP. This systematic review aims to assess the...

Descripción completa

Detalles Bibliográficos
Autores principales: Hoydonckx, Yasmine, McKechnie, Tyler, Peer, Miki, Englesakis, Marina, Kumar, Pranab
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2023
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10294769/
https://www.ncbi.nlm.nih.gov/pubmed/37383673
http://dx.doi.org/10.1080/24740527.2023.2210167

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10294769/
https://www.ncbi.nlm.nih.gov/pubmed/37383673
http://dx.doi.org/10.1080/24740527.2023.2210167

Ejemplares similares